Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: Current status in 37 ESC countries

Steen D. Kristensen, Kristina G. Laut, Jean Fajadet, Zuzana Kaifoszova, Petr Kala, Carlo Di Mario, William Wijns, Peter Clemmensen, Vaja Agladze, Loizos Antoniades, Khalid F. Alhabib, Menko Jan De Boer, Marc J. Claeys, Dan Deleanu, Dariusz Dudek, Andrejs Erglis, Martine Gilard, Omer Goktekin, Giulio Guagliumi, Thorarinn GudnasonKim Wadt Hansen, Kurt Huber, Stefan James, Tomáš Janota, Siobhan Jennings, Olli Kajander, John Kanakakis, Kiril K. Karamfiloff, Sasko Kedev, Ran Kornowski, Peter F. Ludman, Béla Merkely, Davor Milicic, Ruslan Najafov, Francesca A. Nicolini, Marko Noč, Miodrag Ostojic, Hélder Pereira, Dragana Radovanovic, Manel Sabaté, Mohamed Sobhy, Maxim Sokolov, Martin Studencan, Ibrahim Terzic, Steffen Wahler, Petr Widimsky

    Publikation: Bidrag til tidsskriftArtikelForskningpeer review

    Abstrakt

    Aims: Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged. All rights reserved.

    OriginalsprogEngelsk
    Sider (fra-til)1957-1970
    Antal sider14
    TidsskriftEuropean Heart Journal
    Vol/bind35
    Udgave nummer29
    DOI
    StatusUdgivet - 1 aug. 2014

    Fingeraftryk Udforsk hvilke forskningsemner 'Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: Current status in 37 ESC countries' indeholder.

    Citationsformater